Perriman Damien Alaninsider trades

In SEC Form 4 filings, Perriman Damien Alan is listed as Chief Commercial Officer of Exozymes Inc. (EXOZ). Perriman Damien Alan reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Aug 25.

Companies and roles

Company	Role	Transactions	Last filed
EXOZExozymes Inc.	Chief Commercial Officer	2	Aug 25

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-25

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
EXOZExozymes Inc.	Aug 19	Aug 25	M	19,612	not reported	not reported	28,499	No	Form 4
EXOZExozymes Inc.	Aug 19	Aug 25	M · derivative	19,612	$0.00	$0	43,147	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.